United States: Federal Judge Blocks Transgender Protections

Last Updated: January 9 2017
Article by Tabatha L. George, Alexa Greenbaum and Jaklyn Wrigley

Eleventh Hour Ruling Impacts Healthcare Industry On Eve Of Implementation

On Saturday, December 31, 2016, a federal judge in Texas entered a nationwide preliminary injunction barring the enforcement of antidiscrimination protections pertaining to transgender and abortion health services and insurance coverage under the Affordable Care Act (ACA). The decision impacts healthcare providers across the country and may require your immediate attention (Franciscan Alliance, et al. v. Burwell, et al.).

Background: Legal Context Of Section 1557 Of The ACA

Section 1557 of the ACA prohibits discrimination by a covered entity on the basis of race, color, national origin, sex, age, and disability in certain health programs or activities. Notably, it does not prohibit discrimination by a covered entity against its employees unless certain health programs or activities are involved. On May 18, 2016, the Department of Health and Humans Services (HHS) published a final rule titled "Nondiscrimination in Health Programs and Activities," which sought to clarify and codify the nondiscrimination requirements of Section 1557, particularly with respect to the prohibition of discrimination on the basis of sex.

In implementing Section 1557, the Final Rule prohibits discrimination by any health program or activity receiving federal financial assistance on the grounds prohibited under four federal civil rights laws: (1) Title VI of the Civil Rights Act of 1964, (2) Section 504 of the Rehabilitation Act of 1973, (3) Title IX of the Education Amendments of 1972, and (4) the Age Discrimination Act of 1975. Failure to comply could mean a loss of federal funding, debarment from doing business with the government, and false claims liability. 

The Final Rule implementing Section 1557 applies to every health program or activity that receives HHS funding, every health program or activity administered by HHS, such as the Indian Health Service or the Medicare program, and every health program or activity administered by an entity created by Title I of the ACA. Given the broad definition of covered entity, virtually every healthcare provider would be required to comply with the Final Rule.

The Final Rule took partial effect on July 18, 2016; however, for those insurance issuers or group health plans that must alter their plan benefit designs based on the Final Rule, the effective date was scheduled to be the first day of the first plan or policy year on or after January 1, 2017. 

States And Religiously-Affiliated Healthcare Providers Challenge The Final Rule

A group of eight states and three private healthcare providers with religious missions sued HHS and HHS Secretary Sylvia Burwell in the U.S. District Court for the Northern District of Texas challenging the Rule's interpretation of discrimination "on the basis of sex" to include "gender identity" and "termination of pregnancy." They reasoned that Section 1557's scope should be limited by Title IX's binary definition of sex (i.e., the immutable, biological differences between males and females as acknowledged before birth), and that the Rule's failure to include Title IX's religious and abortion exemptions rendered the Rule contrary to law.  

As a result, they argued that the Rule violated the Administrative Procedures Act (a federal law that allows an individual suffering legal wrong because of agency action to file suit against the government) (APA). The Plaintiffs also claimed that the Rule violated the Religious Freedom Restoration Act (RFRA), reasoning that it would have required them to deliver healthcare in such a way that would violate their religious freedom and thwart their independent medical judgment.  

Ultimately, the challengers argued that the Rule's effect would be unconscionable. Either they would be required to perform procedures that constitute an "impermissible material cooperation with evil" or they would be subjected to hefty monetary penalties in the form of civil liability or the loss of billions of dollars in aggregated federal funding.

On October 21, 2016, the group of states and private challengers moved for a preliminary injunction to resolve the matter before the Rule's insurance provision went into effect on January 1, 2017, at which time they contended they would be forced to make significant and expensive changes to their insurance plans. The government opposed the lawsuit, arguing that the Final Rule did not mandate the coverage or performance of any particular procedure, but rather only requires that covered entities provide health services and health insurance in a nondiscriminatory manner.  

The Court Blocks Key Part Of Final Rule Implementing Section 1557

Unlike many of us, Judge Reed O'Connor (a 2007 George W. Bush appointee who previously halted the government's efforts to allow transgender people to use the bathroom that corresponds with their gender identity) was busy over the holiday season. On December 31, 2016 – the eve of the insurance provision's effective date – he issued a nationwide injunction blocking the challenged portion of the Final Rule.

Judge O'Connor sided with the plaintiffs, finding that HHS acted outside its authority and that Congress did not intend the nondiscrimination provisions on the basis of sex to include protections for gender identity or abortion history. If Congress had intended to include a more expansive definition of sex in the ACA, he reasoned, then Congress would not have incorporated Title IX (and its binary definition of sex) into Section 1557. Judge O'Connor also held the Final Rule's failure to incorporate Title IX's religious exemptions rendered the Final Rule arbitrary, capricious, and contrary to the law under the APA.

Judge O'Connor also addressed plaintiffs' arguments that the Final Rule violated the RFRA. Judge O'Conner agreed that the Final Rule placed substantial pressure on plaintiffs to abstain from a sincere religious exercise (i.e., the refusal to perform, refer for or cover gender transition procedures or abortions). He similarly found that the law operated to make the practice of religious beliefs more expensive, which he said also imposed an undue burden.

Although the government may burden one's religious exercise under certain circumstances, to do so it must show that the burden is the least restrictive means in advancing a compelling interest – an interest the government would be willing to pursue itself. Judge O'Connor found that the government was not so inclined because the government's own health insurance programs (i.e., Medicare and Medicaid) do not mandate coverage for transition surgeries and TRICARE, the military's insurance program, specifically excludes such coverage. 

If the government wished to expand access to transition and abortion procedures, Judge O'Connor advised the most straightforward way to achieve this would be for the government to assume the cost or providing them. By requiring the plaintiffs to do so in its place, the judge decided that the Rule likely violated the RFRA.

Inevitability? The Impact of the Trump Administration

Although Judge O'Connor's opinion is a dramatic last-minute development, the outcome may have been inevitable. President-elect Trump has frequently communicated his commitment to repeal and replace the ACA. To further this goal, he has chosen Rep. Tom Price (R-GA) – an outspoken opponent to the ACA – to head HHS in his administration. Price is also opposed to abortion and has characterized the Obama Administration's efforts to expand transgender rights as federal overreach.

Therefore, while Judge O'Connor's opinion may be news today – and it is certainly important given the January 1 effective date – covered entities may have nevertheless found themselves in this position down the line. 

Where Do Covered Entities Go From Here?

Healthcare providers may find themselves scratching their heads at this point. With so much speculation about the impact of a Trump Administration, a possible congressional dismantling of the ACA, and now this development, it may be difficult to pinpoint your obligations under Section 1557. Fortunately, Judge O'Connor was clear that only the portion of the Final Rule that interprets discrimination on the basis of "gender identity" and "termination of pregnancy" is blocked.

The remainder of the Rule implementing Section 1557, which prohibits discrimination in the provision of health services and health insurance coverage on the basis of disability, race, color, age, national origin, or sex (other than gender identity and termination of pregnancy), is now in effect (as of July 18, 2016 or January 1, 2017, depending on the provision). The same is true for the portions of the Final Rule that require or enhance language assistance for people with limited English proficiency, and require covered entities to provide notice of compliance with Section 1557.

If you were prepared to fully comply with the January 1 deadline, you have the option to table at least some of those plans until this issue is resolved. However, you should be aware that individuals may also attempt to use other civil rights statutes, such as Title VII, in order to redress alleged grievances related to a healthcare organization's treatment of transgender individuals. In other words, avoiding liability under the ACA might not necessarily be the end of the story when it comes to legal obligations.

Determining the best option for your organization depends on a variety of factors. If you do decide to make any changes or delay implementation, you may need to communicate that decision to your workforce, patients, and insureds, and you should consult with legal counsel before taking any such actions. 

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Tabatha L. George
Jaklyn Wrigley
In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.